These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 15319398)

  • 1. Commentary: Fifty years of the multistage model: remarks on a landmark paper.
    Moolgavkar SH
    Int J Epidemiol; 2004 Dec; 33(6):1182-3. PubMed ID: 15319398
    [No Abstract]   [Full Text] [Related]  

  • 2. Commentary: Mathematical models of cancer progression and epidemiology in the age of high throughput genomics.
    Frank SA
    Int J Epidemiol; 2004 Dec; 33(6):1179-81. PubMed ID: 15319407
    [No Abstract]   [Full Text] [Related]  

  • 3. Spatial stochastic models for cancer initiation and progression.
    Komarova NL
    Bull Math Biol; 2006 Oct; 68(7):1573-99. PubMed ID: 16832734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene selection for classification of cancers using probabilistic model building genetic algorithm.
    Paul TK; Iba H
    Biosystems; 2005 Dec; 82(3):208-25. PubMed ID: 16112804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multistate and multifactorial progression of gastric cancer: results from community-based mass screening for gastric cancer.
    Liu CY; Wu CY; Lin JT; Lee YC; Yen AM; Chen TH
    J Med Screen; 2006; 13 Suppl 1():S2-5. PubMed ID: 17227633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recursive partitioning analysis of prognostic factors for survival in patients with advanced cancer.
    Chow E; Abdolell M; Panzarella T; Harris K; Bezjak A; Warde P; Tannock I
    Int J Radiat Oncol Biol Phys; 2009 Mar; 73(4):1169-76. PubMed ID: 18938045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimating and modeling the cure fraction in population-based cancer survival analysis.
    Lambert PC; Thompson JR; Weston CL; Dickman PW
    Biostatistics; 2007 Jul; 8(3):576-94. PubMed ID: 17021277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetics: surveillance team against cancer.
    Klein G
    Nature; 2005 Mar; 434(7030):150. PubMed ID: 15758980
    [No Abstract]   [Full Text] [Related]  

  • 9. Prediction of Lynch syndrome in consecutive patients with colorectal cancer.
    Green RC; Parfrey PS; Woods MO; Younghusband HB
    J Natl Cancer Inst; 2009 Mar; 101(5):331-40. PubMed ID: 19244167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How effective are disease-modifying drugs in delaying progression in relapsing-onset MS?
    Brown MG; Kirby S; Skedgel C; Fisk JD; Murray TJ; Bhan V; Sketris IS
    Neurology; 2007 Oct; 69(15):1498-507. PubMed ID: 17699802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer: caught in time.
    Spinney L
    Nature; 2006 Aug; 442(7104):736-8. PubMed ID: 16915260
    [No Abstract]   [Full Text] [Related]  

  • 12. Commentary: The age distribution of cancer and a multistage theory of carcinogenesis.
    Doll R
    Int J Epidemiol; 2004 Dec; 33(6):1183-4. PubMed ID: 15522923
    [No Abstract]   [Full Text] [Related]  

  • 13. Age, period and cohort effects in Bayesian smoothing of spatial cancer survival with geoadditive models.
    Sauleau EA; Hennerfeind A; Buemi A; Held L
    Stat Med; 2007 Jan; 26(1):212-29. PubMed ID: 16526007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pain, sleep disturbance, and fatigue in patients with cancer: using a mediation model to test a symptom cluster.
    Beck SL; Dudley WN; Barsevick A
    Oncol Nurs Forum; 2005 May; 32(3):542. PubMed ID: 15897927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A cluster model for space-time disease counts.
    Yan P; Clayton MK
    Stat Med; 2006 Mar; 25(5):867-81. PubMed ID: 16453380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting nonmuscle invasive bladder cancer recurrence and progression in patients treated with bacillus Calmette-Guerin: the CUETO scoring model.
    Fernandez-Gomez J; Madero R; Solsona E; Unda M; Martinez-Piñeiro L; Gonzalez M; Portillo J; Ojea A; Pertusa C; Rodriguez-Molina J; Camacho JE; Rabadan M; Astobieta A; Montesinos M; Isorna S; Muntañola P; Gimeno A; Blas M; Martinez-Piñeiro JA
    J Urol; 2009 Nov; 182(5):2195-203. PubMed ID: 19758621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival prediction of patients with advanced cancer: the predictive accuracy of the model based on biological markers.
    Kikuchi N; Ohmori K; Kuriyama S; Shimada A; Nakaho T; Yamamuro M; Tsuji I
    J Pain Symptom Manage; 2007 Dec; 34(6):600-6. PubMed ID: 17629667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relative risk and acceleration in lung cancer.
    Berry G
    Stat Med; 2007 Aug; 26(18):3511-7. PubMed ID: 17177175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Model uncertainty and risk estimation for experimental studies of quantal responses.
    Bailer AJ; Noble RB; Wheeler MW
    Risk Anal; 2005 Apr; 25(2):291-9. PubMed ID: 15876205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p53 mutations in deep tissues are more strongly associated with recurrence than mutation-positive mucosal margins.
    Huang X; Pateromichelakis S; Hills A; Sherriff M; Lyons A; Langdon J; Odell E; Morgan P; Harrison J; Partridge M
    Clin Cancer Res; 2007 Oct; 13(20):6099-106. PubMed ID: 17947474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.